We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Topical Patch Provides Dermal Analgesia

By HospiMedica staff writers
Posted on 07 Jul 2006
A new anesthetic patch is designed to prevent pain in patients prior to venous access and dermatologic procedures, and it can be used in children over the age of three.

Synera, manufactured by Endo Pharmaceuticals (Chadds Ford, PA, USA), is a two-step, peel-and-stick topical patch that consists of a thin, uniform, local anesthetic formulation together with an integrated, oxygen-activated heating component intended to enhance the delivery of the anesthetic. The drug formulation is a eutectic mixture of lidocaine 70 mg and tetracaine 70 mg. The recommended application time for the Synera patch is 20 to 30 minutes before the procedure. Synera is the first self-contained topical patch for prevention of pain associated with superficial venous access and superficial dermatologic procedures in patients three years of age and older.

We believe Synera offers patients and caregivers greater utility and convenience over currently available treatments for those who may experience pain with needle sticks, said Peter A. Lankau, president and chief executive officer of Endo Pharmaceuticals.
"Endo is pleased to offer this exciting and innovative therapy to healthcare professionals for their adult and pediatric patients.”

"Pain caused by superficial venous access procedures--such as IV infusions and blood draws--can and should be anticipated and prevented, said Susan T. Verghese, M.D., a pediatric anesthesiologist and professor at the departments of anesthesiology and pediatrics at George Washington University Medical Center (Washington, DC, USA).

Hospitalized children are routinely subjected to multiple superficial venous access procedures such as IV infusions and blood draws.



Related Links:
Endo Pharmaceuticals

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
MRI System
Ingenia Prodiva 1.5T CS
New
Family Practice Exam Table
2100M7

Latest Patient Care News

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization